Latest news
Loading news…
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
BioVectra on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
BioVectra was acquired by Agilent Technologies in 2024 for $925M.
Total Funding
$77.3M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
322
About BioVectra
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Charlottetown, Prince Edward Island, Canada
BioVectra Funding Rounds
2 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–2 of 2Show
Page 1 / 1
BioVectra Key People
Chief Science Officer
Chief Commercial Officer
Founder
VP Strategic Projects
322
professional contacts at BioVectra
Contact execs at BioVectra →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about BioVectra
People who checked this page also checked these
Browse the full Acquirezy directory.